Tao Xin

This inventor holds 29 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Astrazeneca Ab, Nps Allelix Corporation, Nps Pharmaceuticals, Inc.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao Xin. Retrieved from https://idiyas.com/inventor/tao-xin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 10)

% Patents Active = 51.7

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 188(Granted Patents)

Location History:

North York, CA (1999 - 2003)
Mississauga, CA (2009 - 2010)
Ontario, CA (2005 - 2011)
Toronto, CA (2001 - 2012)
Woodbridge, CA (2004 - 2024)

Company Filing History:

Nps Allelix Corporation

patents

4 out of 93

Nps Pharmaceuticals, Inc.

patents

4. 2 out of 69

Allelix Biopharmaceuticals Inc.

Apotex Technologies Inc.

patents

7. 2 out of 3

Pharmala Biotech Inc.

patents

8. 1 out of 1

Nps Allelix Biopharmaceuticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Serotonin Receptor Modulators

Heterocyclic Compounds

Migraine Treatments

Fluorinated Compounds

Azaindoles

Tetrazole Compounds

Metabotropic Glutamate Receptors

Pharmaceutically Active Compounds

Bicyclic Compounds

Piperidine

Indoles

Quinolone Derivatives

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679817 - Processes for the preparation of the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and N-methyl-1,3-benzodioxolylbutanamine (MBDB) (2026-07-14),

2. 12042478 - (R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereof (2024-07-23),

3. 9938240 - Fluorinated derivatives of 3-hydroxypyridin-4-ones (2018-04-10),

4. 9550733 - Fluorinated derivatives of 3-hydroxypyridin-4-ones (2017-01-24),

5. 9073865 - Fluorinated derivates of 3-hydroxypyridin-4-ones (2015-07-07),

6. 8148394 - Azaindoles having serotonin receptor affinity (2012-04-03),

7. 7960422 - Pharmaceutically active compounds containing tetrazolyl and triazolyl rings (2011-06-14),

8. 7902401 - Fluorinated compounds (2011-03-08),

9. 7772235 - mGluR5 modulators (2010-08-10),

10. 7691892 - Tetrazole compounds and their use as metabotropic glutamate receptor antagonists (2010-04-06),

11. 7678796 - MGluR5 modulators I (2010-03-16),

12. 7576077 - Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists (2009-08-18),

13. 7476684 - Compounds for the treatment of neurological, psychiatric or pain disorders (2009-01-13),

14. 7456200 - Compounds (2008-11-25),

15. 7268127 - Azaindoles having serotonin receptor affinity (2007-09-11),

Title: Inventor Tao Xin: Revolutionizing Technology in Toronto

Introduction: Tao Xin is a visionary inventor based in Toronto, Canada, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tao Xin holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Tao Xin has worked with leading tech companies and research institutions, spearheading projects that have pushed the boundaries of technological advancement.

Collaborations: Throughout his career, Tao Xin has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and knowledge-sharing in the tech industry.

Conclusion: Inventor Tao Xin's relentless pursuit of innovation and his passion for creating cutting-edge technologies have solidified his reputation as a trailblazer in the field of technology in Toronto and beyond.

Profile summary based on public USPTO records.